CN219049394U - Health care device - Google Patents

Health care device Download PDF

Info

Publication number
CN219049394U
CN219049394U CN202222718849.5U CN202222718849U CN219049394U CN 219049394 U CN219049394 U CN 219049394U CN 202222718849 U CN202222718849 U CN 202222718849U CN 219049394 U CN219049394 U CN 219049394U
Authority
CN
China
Prior art keywords
health care
cone
low
frequency wave
frequency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202222718849.5U
Other languages
Chinese (zh)
Inventor
李明顺
曾锦松
曾旭晖
曾献庆
李威龙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiwan Oasis Technology Co Ltd
Original Assignee
Taiwan Oasis Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiwan Oasis Technology Co Ltd filed Critical Taiwan Oasis Technology Co Ltd
Priority to CN202222718849.5U priority Critical patent/CN219049394U/en
Application granted granted Critical
Publication of CN219049394U publication Critical patent/CN219049394U/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Percussion Or Vibration Massage (AREA)

Abstract

The utility model provides a health care device, which at least comprises a low-frequency wave emitter and a cone, wherein the low-frequency wave emitter is connected with the bottom surface of the cone; wherein the low frequency wave transmitter is capable of transmitting a low frequency wave of a predetermined frequency, the predetermined frequency being between 1.27 and 1.81 Hz. The health care device can increase the contents of activated T cells and B cells in blood and increase the poisoning capability of NK cell lines on cancer tumor cell lines (K562) so as to achieve the health care effects of convenient operation, accurate identification of the use position, non-invasiveness, non-contact and no damage caused by excessive energy risks.

Description

Health care device
Technical Field
The present utility model relates to a health care device, and more particularly, to a health care device for transmitting low frequency waves to a human body to perform health care of the human body.
Background
The known health care modes at present include scraping, cupping, acupuncture, massaging and the like, and the health care purposes can be achieved, but the known health care modes also have the defects such as: scraping can cause damage to the skin, increasing the risk of infection; the cupping effect is close to scraping, but the use needs to be contacted with the skin by the cup body, so the cleaning and sanitation of the cup body are considered; acupuncture is performed by making needles invade the corresponding acupoints of the human body, thus having invasive risks; massage, while not risking invasiveness, relies on others to help relax muscles.
The improvement of the above mentioned health care method includes the non-invasive radiation health care device for human body acupoints, such as microwave acupuncture instrument, which uses microwave oscillator with oscillation frequency as high as 1000-2000 megahertz (MHz), which is easy to damage due to excessive radiation (energy). In fact, the microwave acupuncture apparatus is also required to correspond to the acupoints of human body to exert efficacy, however, the general person is not a professional related to traditional Chinese medicine, and cannot accurately identify the acupoints of each person, so the microwave acupuncture apparatus is not a universal health care apparatus in practice.
Therefore, development of a health care device and a health care method which can be conveniently operated, accurately identify a use position, are non-invasive, non-contact and free from damage caused by excessive energy risk is a trend in the industry.
Disclosure of Invention
The utility model aims to solve the technical problem of providing a health-care device and a health-care method which can be conveniently operated, accurately identify the use position, are non-invasive and non-contact, and do not cause damage due to excessive energy risk.
The utility model is mainly based on the recognition that the main tissue and organ of the human body (referring to organism, not artificial tissue or organ) has an inherent oscillation frequency, for example, the head is 8-12Hz, the chest is 4-6Hz, the heart is 5Hz, the abdominal cavity is 6-9Hz, the blood flow frequency is 1.2Hz, and the bone tissue is 1.8Hz. When a certain part of the human body is in a low-frequency wave field of 0-20Hz, such as low-frequency electromagnetic waves, such as bass waves or infrasonic waves (which are relatively called ultrasonic waves or ultrasonic waves higher than 20 kHz), if the sound pressure intensity (Sound Pressure Level, in dB) reaches a certain threshold value, the elastic wall on the outer layer of the tissue organ corresponding to the part is first brought into a vibration state, and then the vibration is conducted to the inside of the tissue organ. In particular, resonance occurs when the frequency of the bass wave is synchronized with the aforementioned natural oscillation frequency of the tissue organ, at which time the tissue organ is subjected to the greatest stimulus. When acting on a tissue organ in a resonance mode induced by bass waves, it acts on the cellular structure of the tissue organ, such as the granuloma (mitochondron) of the cell, which is the main site of oxidative phosphorylation within the cell and synthesis of Adenosine Triphosphate (ATP), providing chemical energy for the cell's activity, so there is a "cellular power station" (the powerhouse of the cell).
ATP refers to the membrane potential (membrane potential, transmembrane potential or membrane voltage) of the cell membrane, which is a membrane composed of a phospholipid bilayer (phospholipid bilayer), and almost all cell membranes of cellular organisms are mainly composed of a phospholipid bilayer, the inside of which is filled with a dielectric, so that the cell membrane composed of a phospholipid bilayer is equivalent to a capacitor in electrical properties. The cell membrane is structured not only with phospholipid bilayer but also with proteins, some of which act as ion channels to allow ions (e.g. positively charged sodium ions na+ and potassium ions k+) to be transported across the cell membrane. This phenomenon can be understood by physics, that is, the cell membrane is a capacitor with electrical leakage, which is the passage of electrical leakage current (ion transport) through the capacitor.
In addition, resonance induced by the aforementioned bass wave acts on the granulosa body to affect the binding state of some enzymes such as ATP hydrolase (ATPase) to the cell membrane and the activity of the enzymes. ATPase is an enzyme that breaks down ATP to generate energy and activates na+ and k+, and is therefore also known as na+ -k+ ATPase or na+ -k+ pump (na+ -k+ pump) that regulates sodium and potassium ion concentrations inside and outside the cell membrane such that the membrane potential is regulated, e.g. reverting from action potential to resting membrane potential (resting membrane potential). First, the cell membrane is at a resting membrane potential, and then the action potential generated by appropriate stimulation of the cell membrane in a resting membrane potential state is typically sequentially subjected to the following phases: polarization (depolarization), depolarization (repolarization), repolarization (repolarization), hyperpolarization (hyperpolarization), in particular when the action potential during the hyperpolarization phase is lower than the resting membrane potential, it is necessary to rely on the na+ -k+ pump to assist the return of the action potential to the resting membrane potential during the hyperpolarization phase. Thus, it is understood that long-term exposure to stimuli (e.g., stress) or long-term inflammatory conditions in humans, or a long-term lack of ATP and/or ATPase, can result in cells that are in a hyperpolarization stage for a long period of time such that the membrane potential is below the resting membrane potential.
Based on the understanding that the cell membrane is electrically equivalent to a capacitor (or a battery), the membrane potential corresponds to the voltage of the battery, and the membrane potential of the action potential in the hyperpolarization stage is lower than the rest membrane potential, wherein the membrane potential of the action potential in the hyperpolarization stage can be understood as the residual electric quantity (voltage) of the battery after the electric quantity is already consumed after the battery is used, and the rest membrane potential can be correspondingly the initial electric quantity (voltage) of the electric quantity which is not consumed or is refilled. It was counted that there were 37.2 megacells on average in humans, in other words 37.2 megacells "on average" in humans. It will be appreciated that when the body is under stress or inflamed for an extended period of time, the cells are correspondingly in a "battery power depleted" state in the hyperpolarized stage for an extended period of time, so that the cells are unable to perform or maintain their intended function, and the human tissue and organ thus exhibit pathological or tired phenomena. However, at this time, if a low frequency wave of a certain intensity and/or frequency is applied to the cells, the energy of the wave may be converted into heat energy, biochemical energy and bioelectric energy to increase the activity of ATPase, thereby affecting the return of the membrane potential of ATPase to the resting membrane potential in the hyperpolarization stage, which causes the return to the initial charge (voltage) of the full charge of the resting membrane potential corresponding to the aforementioned "battery" of human cells from the aforementioned "battery charge depleted" state of the membrane potential in the aforementioned hyperpolarization stage. In other words, the low frequency wave can "charge" the cells in the hyperpolarization stage, so that the damaged tissue can be repaired under the stimulation of the low frequency wave by acting on the tissue organ. One example of the relationship between low frequency waves and organisms is that the frequency of the schumann resonance (Schumann Resonance) in very low frequency (Extremely Low Frequency, ELF) in low frequency waves is 7.83 Hz, which is just the same as the frequency of the hippocampus of the brain of mammals, especially the alpha wave and theta wave of the brain of humans are also approximately 8Hz, so the National Aviation and Space Agency (NASA) installs a schumann wave generator in the space-carrying space to maintain the physical and mental health of the spaceman in space. For an increase in ATPase activity by low frequency waves, see "Effects of low frequency magnetic fields on Na, K-ATPase activity, M.Blank, L.Soo, V.Papstein, bioelectrochemistry and Bioenergetics (1995) 267-273", wherein low frequency waves (magnetic waves) of 0-70Hz are used, resulting in an increase in Na+ -K+ ATPase activity of 5-10%. In other words, the low frequency wave may "charge" the cells in the hyperpolarization stage by activating the cells, and thus the low frequency wave may be applied to "cell activation technology". In particular, the low-frequency wave may include an electromagnetic wave such as an electric wave, a magnetic wave, or an optical wave, or a bass wave.
In addition, the utility model recognizes that according to the theory of traditional Chinese medicine, the navel of a human body is the Shenque point and is the place where the conception vessel, the governor vessel, the belt vessel and the pulse pass, so that when the Shenque point is stimulated, the whole body can be regulated by connecting the meridians with the viscera and six fu organs. Furthermore, according to the theory of Western medicine, the navel is the thinnest part of the epidermal horny layer in the abdomen of the human body and has no adipose tissue under the navel, so the barrier function is the weakest. In addition, since navel skin has a rich venous network and branches of the abdominal artery in addition to the microcirculation blood vessels of general skin, it is possible to bring the effect or change into the blood circulation system of the human body by only performing a certain effect or change on blood in the microcirculation blood vessels of navel skin. Moreover, the navel of the human body can be easily identified, and the position of the navel can not be different according to the body height, fat and thin of the human body, so that the navel is used as a health care device to be applied to the corresponding position of the human body, and the navel has the advantage that a user can accurately identify the using position.
The utility model recognizes that the low-frequency wave emitter (such as low-frequency electric wave emitter, low-frequency magnetic wave emitter, low-frequency sonic wave emitter) which can generate low-frequency waves (such as low-frequency electric wave emitter, low-frequency magnetic wave emitter, low-frequency sonic wave emitter) can emit the low-frequency waves towards the navel in a way of not contacting with the navel so as to achieve the effect similar to acupuncture, thereby achieving a non-invasive and non-contact health care way. Preferably, the bass wave emitter capable of generating bass waves is used for emitting the bass waves towards the navel in a mode of not contacting with the navel so as to achieve the effect similar to acupuncture, thus a non-invasive and non-contact health care mode can be achieved, and particularly, the bass waves, the low-frequency sound waves and the low-frequency sound waves refer to the same meaning. If the bass wave is directly used as the element of the health care device, the problem of damage caused by excessive energy risk generated by the high-frequency microwave oscillator can be avoided, and meanwhile, adverse effects of electric waves or magnetic waves on people with special physique can be avoided.
Since the effect similar to acupuncture can be achieved by recognizing the bass wave, the influence of acupuncture on the immune system is that the acupuncture can increase the content of Interferon gamma (gamma-IFN) and neuropeptide beta-endorphin (beta-enkephalin) to activate NK cells (natural killer cell), and the NK cells can secrete cytokines (cytokine) which can regulate and control inflammatory reaction. NK cells, which are immune cells and are formed by the development of bone marrow lymphoid stem cells, are large-grained lymphocytes in the cytoplasm, and are mainly distributed in peripheral blood (including blood in microcirculation) and spleen, and are also present in small amounts in lymph nodes and other tissues.
Based on the above-mentioned "navel is the thinnest place of the epidermal horny layer in the human abdomen and there is no adipose tissue under the navel, the barrier function thereof is the weakest. In addition, navel skin has abundant venous network and abdominal artery branches in addition to general skin having microcirculation blood vessels, so that it is possible to bring the effect or change into the blood circulation system of human body as long as it is performed with a certain effect or change of blood in the navel skin microcirculation blood vessels, and thus, when a bass wave is emitted toward navel with a bass wave emitter, an acupuncture-like effect is induced, so that the content of gamma-IFN and beta-enkephalin in blood in the navel skin microcirculation blood vessels is increased to activate NK cells, B cells (B cells, B lymphocyte) and activated T cells (Active T cells, active T lymphocyte), and inflammatory reaction or secretion of antibodies can be regulated because NK cells, B cells and activated T cells secrete cytokines. In addition, when a bass wave is emitted towards the navel by a bass wave emitter, the activity of Na+ -K+ATPase of activated T cells in blood in the microcirculation blood vessel of the navel skin is also increased, so that the activity of the activated T cells can be improved; in other words, when a bass wave is emitted toward the navel with a bass wave emitter, activated T cells having low activity can be "charged" to restore the activity, so that the activated T cells after being "charged" can be re-examined. Therefore, the efficacy of the health care device can be verified by detecting the content change of NK cells, B cells or activated T cells in blood; of course, the ability of NK cell lines to kill cancer tumor cell lines (K562) can also be used, for example, by measuring the ability of NK cells to kill target cells (Effector to target cell ratio, E/T ratio) in a mixed culture sample and comparing the differences in the results to verify the feasibility of the utility model. The technical means of the utility model is as follows: a health-care method is disclosed, which features that a low-frequency wave emitter is used to emit a low-frequency wave with a predefined frequency toward the navel at a predefined position in front of and at a predefined distance from the navel.
Based on the above description, the present utility model provides a health care device, which is disposed in front of a navel of a user and forms a predetermined position of a predetermined distance from the navel, and the health care device at least comprises a low frequency wave emitter.
Based on the above description, the present utility model provides a health care method, in which a health care device is disposed at a predetermined position in front of and forming a predetermined distance with a navel of a user, and a low frequency wave with a predetermined frequency is emitted toward the navel by the health care device; wherein, this health care device contains at least: a low frequency wave emitter, a column and a cone; the column body is provided with a column body top surface, a column body bottom surface and a column body with two ends respectively connected with the column body top surface and the column body bottom surface; the cone is provided with a vertex, a cone bottom surface and a cone body with two ends respectively connected with the vertex and the cone bottom surface; and the top surface of the cylinder is correspondingly jointed with the bottom surface of the cone, and the low-frequency wave emitter is connected with the bottom surface of the cylinder.
In one embodiment, the predetermined position is located on a virtual bottom surface of a virtual cone having the navel as a virtual vertex, and the predetermined distance is between 5 cm and 8 cm; the preset position is positioned at the center of the virtual bottom surface, the virtual cone is a cone, the preset position is positioned at the center of the circular virtual bottom surface, and the preset distance is the distance between the center of the circle and the navel. Wherein the vertex is located at the predetermined position.
In one embodiment, the vertex is further provided with a vertically-arranged rod body facing away from the cone bottom surface, and the length direction of the rod body is coincident with a cone bottom surface normal line passing through a cone bottom surface center of the cone bottom surface and faces the navel. Wherein a tip of the stick is located at the predetermined position.
Based on the above description, the present utility model provides a health care device, which at least comprises a low frequency wave emitter, a column and a cone; the column body is provided with a column body top surface, a column body bottom surface and a column body with two ends respectively connected with the column body top surface and the column body bottom surface; the cone is provided with a vertex, a cone bottom surface and a cone body with two ends respectively connected with the vertex and the cone bottom surface; the top surface of the cylinder is correspondingly jointed with the bottom surface of the cone, and the low-frequency wave emitter is connected with the bottom surface of the cylinder; wherein the low frequency wave transmitter is capable of transmitting a low frequency wave of a predetermined frequency.
Alternatively, the utility model provides a health care device, which at least comprises a low-frequency wave emitter and a cone; the cone is provided with a vertex, a cone bottom surface and a cone body with two ends respectively connected with the vertex and the cone bottom surface; and the low-frequency wave emitter is connected with the cone bottom surface; wherein the low frequency wave transmitter is capable of transmitting a low frequency wave of a predetermined frequency.
In one embodiment, the predetermined frequency is between 1.27 and 1.81 Hz.
In one embodiment, the predetermined frequency is 1.45Hz.
In one embodiment, the cone is an integrally formed wooden cone.
Based on the above description, the present utility model provides still another health care method, in which a health care device as described above is disposed at a predetermined position in front of and forming a predetermined distance with a navel of a user, and the low frequency wave of the predetermined frequency is emitted toward the navel by the health care device as described above.
The beneficial effects of the utility model are as follows: the health care device and the health care method can achieve the health care effects of being convenient to operate, accurately identifying the using position, being non-invasive, non-contact and free from damage caused by excessive energy risk.
Drawings
FIG. 1 is a schematic diagram of the health care method of the present utility model in practice.
Fig. 2 is a schematic structural view of the health care device for performing the health care method according to the present utility model.
Fig. 3 is a schematic structural view of the health care device of the present utility model.
Fig. 4 is a schematic structural view of the health care device provided with the pipeline according to the present utility model.
Fig. 5 is a schematic structural view of the health care device provided with the upright type stick body of the present utility model.
Fig. 6 is a schematic structural view of the health care device of the present utility model disposed on a frame.
Fig. 7 is a schematic view showing a structure in which a low-frequency wave emitter of the health care device of the present utility model is disposed on the bottom surface of a cone.
Description of the figure:
1: user' s
11: navel
2: low frequency wave transmitter
21: power supply
22: vibrating piece
200: frame body
100: health care device
3: column body
31: column top surface
32: column bottom surface
33: column body
4: cone body
40: vertex point
401: rod body
402: tip of stick body
41: cone bottom surface
42: cone body
5: pipeline
C: center of cone bottom surface
D: predetermined distance
N: cone bottom surface normal
P: predetermined position
S: virtual cone
S1: virtual vertex
S2: virtual bottom surface
W: low frequency waves.
Detailed Description
Referring to fig. 1, in a health care method provided by the present utility model, a low frequency wave W with a predetermined frequency is emitted toward a navel 11 by a low frequency wave emitter 2 at a predetermined position P in front of the navel 11 of a user 1 and forming a predetermined distance D with the navel 11. The aforementioned "front" refers to the front of the abdomen of the human body and corresponds to the "rear" of the back of the human body, and the predetermined position P is located on a virtual bottom surface S2 of a virtual cone S with the navel 11 as a virtual vertex S1, such that the predetermined distance D is not more than 8 cm, or the predetermined distance is not less than 5 cm, or the predetermined distance D is between 5 cm and 8 cm. Preferably, the predetermined position P is located at the center of the virtual bottom surface S2, for example, the virtual cone S is a cone and the predetermined position P is located at the center of the circular virtual bottom surface S2 and the predetermined distance D is between 5 cm and 8 cm from the navel 11.
The low-frequency wave emitter 2 is preferably a low-frequency wave transducer, so the low-frequency wave W may be a low-frequency wave, the low-frequency wave transducer includes a power source 21 and a vibrating member 22, the vibrating member 22 is electrically connected to the power source 21, the vibrating member 22 is a disc-shaped piezoelectric ceramic transducer made of piezoelectric material polarized in a thickness direction, the power source 21 provides power to the vibrating member 22 to vibrate the vibrating member 22 in the thickness direction to generate the low-frequency wave with the predetermined frequency, wherein the predetermined frequency is not more than 1.81Hz, or the predetermined frequency is not less than 1.27Hz, or the predetermined frequency is between 1.27Hz and 1.81 Hz. Optimally, the predetermined frequency is 1.45Hz.
In other words, the present utility model also provides a health care device disposed in front of a navel 11 of a user 1 and forming a predetermined position P of a predetermined distance D with the navel 11, the health care device at least comprising a low frequency wave emitter 2.
< detection method and Effect >
The foregoing healthcare method is performed for the person A1 and the person A2, wherein the predetermined distance D is 5 cm, the predetermined frequency is 1.45Hz, and the low frequency wave is a bass wave. The age of the A1 person is 74 years, male; age of A2 person is 72 years, female. Before the health care method is executed, immunological examination is carried out on the A1 personnel and the A2 personnel for blood sampling and delivery medical examination, and the content percentage of the activated T cells is examined. The A1 person was again subjected to the immunological test for blood sampling and delivery of the medical test at 19 days after 2 hours of the above-mentioned health method, and the A2 person was also subjected to the immunological test for blood sampling and delivery of the medical test at 42 days after 2 hours of the above-mentioned health method, and the percentage of activated T cells was also examined in the same manner, and the results were shown in Table one below.
List one
Figure BDA0003891799420000071
Figure BDA0003891799420000081
It can be seen from Table one that the A1 person had an activated T cell content of 6.2% before the above-mentioned health method was performed, and the activated T cell content after the above-mentioned health method was performed was increased by 12.8%, and the change rate was 206.5%, that is, the activated T cell content was increased by 106.5%. A2 personnel had an activated T cell content of 5.3% before the health care method was performed, and an activated T cell content after the health care method was performed was increased by 7.9%, and the change rate was 149%, that is, the activated T cell content was increased by 49%. Therefore, the health care method provided by the utility model can promote proliferation of the activated T cells, and can increase the content of the activated T cells only by executing for 2 hours once, and can still maintain 49% increase even after 42 days. Obviously, the health care method of the utility model is deeply effective and can maintain long-term health care efficacy.
< detection method and Effect two >
The foregoing healthcare method was performed for 14 persons, respectively, wherein the predetermined distance D was 5 cm, the predetermined frequency was 1.45Hz, and the low frequency wave was a bass wave. Before the health care method is executed, 14 persons are respectively subjected to an immunological examination by blood sampling and delivery medical examination, and the content percentage of B cells (CD19+) is examined. Again, the 14 persons were again subjected to an immunological test on day 19 after 2 hours of the execution of the above-described healthcare method, as was the B-cell percentage test. The average results of 14 persons are shown in Table II below.
Watch II
Figure BDA0003891799420000082
As can be seen from Table II, the average B cell content of 14 persons before the above-mentioned health method was 12.2%, the average B cell content after the above-mentioned health method was 13.6% increased, and the change rate was 111.4%, that is, the B cell content was 11.4% increased. Therefore, the health care method provided by the utility model can promote the proliferation of B cells, and the content of the B cells can be increased only by executing the health care method for 2 hours once. Obviously, the health care method of the utility model has deep effective health care effect.
< detection method and Effect three >
The health care method is carried out on the person B1 and the person B2, wherein the preset distance D is 5 cm, the preset frequency is 1.45Hz, and the low-frequency wave is a low-frequency wave. Before the health care method is executed, blood is sampled for the B1 person and the B2 person. Again, blood was sampled for both B1 and B2 persons on day 19 after 2 hours of performance of the healthcare method described above. The two blood sampling samples were mixed and co-cultured with NK cells in blood and cancer tumor cell lines (K562) at a ratio of 6.25:1 (effect: target), and the death of the cancer tumor cell lines was analyzed, so that the capacity percentage of NK cells to kill cancer tumor cell lines was obtained (the related art can be operated by referring to the taiwan patent with the publication No. TWI 439275B), and the results are described in the following Table III.
Watch III
Figure BDA0003891799420000091
From Table III, it can be seen that the NK cell line of the B1 person before the above-mentioned health method was carried out had a poisoning ability to the cancer tumor cell line (K562) of 24.3%, and the poisoning ability after the above-mentioned health method was carried out was increased to 33.6%, and the change rate was 138.3%, that is, the poisoning ability was increased by 38.3%. B2 personnel have 5.5% of the NK cell line poisoning ability to the cancer tumor cell line (K562) before the health care method is executed, 7.2% of the NK cell line poisoning ability after the health care method is executed is increased, and the change rate is 131%, namely 31% of the poisoning ability is increased. Therefore, the health care method provided by the utility model can promote the increase of the poisoning capability of NK cell strains to cancer tumor cell strains (K562). Obviously, the health care method of the utility model is deeply effective and can maintain long-term health care efficacy.
Referring to fig. 2 and 3, the present utility model further provides a health care device 100 for performing the health care method, wherein the health care device 100 comprises the low frequency wave emitter 2, a cylinder 3 and a cone 4. The column 3 is preferably a cylinder having a column top surface 31, a column bottom surface 32, and a column body 33 having both ends connected to the column top surface 31 and the column bottom surface 32, respectively. The cone 4 has a vertex 40, a cone bottom 41 and a cone 42 with two ends connected to the vertex 40 and the cone bottom 41, respectively. Wherein the cylindrical top surface 31 is correspondingly engaged with the conical bottom surface 41, for example, by welding or screw locking. Preferably, the column 3 and the cone 4 are respectively a metal column and a metal cone. More preferably, the pillar 3 and the cone 4 are integrally formed, in other words, the pillar top 31, the pillar body 33, the cone 42 and the apex 40 are integrally formed.
The low frequency wave emitter 2 is connected to the bottom surface 32 of the column, preferably the low frequency wave emitter 2 is directly connected to the bottom surface 32 of the column, for example, the low frequency wave emitter 2 is welded or screwed to the bottom surface 32 of the column, so that the vibration member 22 generates the low frequency wave W of the predetermined frequency when the power source 21 is activated (refer to fig. 1 again). Then, the low frequency wave W is transmitted to the column bottom 32, and then is transmitted to the cone bottom 41 and the peak 40 of the cone 4 by the column 33, and is formed into a cone shape by the wider cone bottom 41 and the narrower cone bottom 40 of the cone 4, so that the energy of the low frequency wave W is concentrated as it is transmitted to the peak 40. Therefore, when the low frequency wave W is transmitted to the vertex 40, the energy thereof is concentrated to the maximum and emitted from the vertex 40 toward the navel 11; since the apex 40 of the cone 4 is a tip, the low frequency wave W can form a principle similar to "tip discharge" in electricity to concentrate the energy of the low frequency wave W to the apex 40 to be discharged and emitted toward the navel 11. Specifically, the vertex 40 is located at the predetermined position P.
Referring to fig. 4, in another embodiment, the low frequency wave emitter 2 is connected to the bottom surface 32 of the column by a pipe 5, and the low frequency wave W is transmitted from the low frequency wave emitter 2 to the bottom surface 32 of the column by the pipe 5, and then transmitted to the vertex 40 and emitted toward the navel 11 as described above. The power source 21 and/or the vibrating member 22 of the low frequency wave transmitter 2 can be far away from the human body by the arrangement of the pipeline 5, so as to avoid the interference of the electronic device implanted in the human body.
Referring to fig. 5, in another embodiment, a vertical rod 401 is further disposed at the vertex 40 in a direction away from the cone bottom 41, preferably the rod 401 is a metal rod such as a wire or a wire, and the length direction of the rod 401 coincides with the cone bottom normal N passing through the cone bottom center C of the cone bottom 41 and faces the navel 11. Accordingly, the energy of the low frequency wave W can be more guided to be concentrated at a rod tip 402 of the rod 401 to be discharged and emitted toward the navel 11. Specifically, the tip 402 of the wand is now positioned at the predetermined position P.
Referring to fig. 6, in another embodiment, the health care device 100 is disposed on a stand 200, the user 1 is lying on a platform (not shown), the stand 200 is mounted on the platform, and the health care device 100 is located above the navel of the user. In this way, the user can also get a proper rest during the healthcare process.
Referring to fig. 7, in another embodiment, the health care device 100 may also include the low frequency wave emitter 2 and the cone 4, but not include the column 3, the low frequency wave emitter 2 is disposed on the cone bottom 41, the low frequency wave emitter 2 is connected to the cone bottom 41, preferably the low frequency wave emitter 2 is directly connected to the cone bottom 41, for example, the low frequency wave emitter 2 is adhered, welded or screwed to the cone bottom 41, so that the vibrating member 22 generates the low frequency wave W of the predetermined frequency after the power source 21 is started (refer to fig. 1 again). Then, the low-frequency wave W is transmitted to the cone bottom surface 41 and the peak 40 of the cone 4, and the cone 4 is formed into a cone shape from the wider cone bottom surface 41 to the narrower cone bottom surface 40, so that the energy of the low-frequency wave W is concentrated as it is transmitted to the peak 40. Preferably, the cone 4 is an integrally formed wooden cone.

Claims (11)

1. A health care device, which is characterized in that the device at least comprises a low-frequency wave emitter (2) and a cone (4); the cone (4) is provided with a vertex (40), a cone bottom surface (41) and a cone body (42) with two ends respectively connected with the vertex (40) and the cone bottom surface (41); and, the low-frequency wave emitter (2) is connected to the cone bottom surface (41); wherein the low-frequency wave transmitter (2) is capable of transmitting a low-frequency wave (W) of a predetermined frequency.
2. The healthcare device of claim 1, wherein the predetermined frequency is between 1.27 and 1.81 Hz.
3. The healthcare device of claim 2, wherein the predetermined frequency is 1.45Hz.
4. A health care device as claimed in claim 3, characterized in that the low-frequency wave emitter (2) is a bass wave transducer and the low-frequency wave (W) is a bass wave.
5. The device according to claim 4, wherein the structure of the bass transducer comprises a power source (21) and a vibrating member (22), and the vibrating member (22) is electrically connected to the power source (21).
6. The health care device as claimed in claim 5, characterized in that the vibrating element (22) is a piezo-ceramic transducer in the form of a disk.
7. The healthcare device according to claim 6, wherein the cone (4) is an integrally formed wooden cone.
8. The device according to claim 7, wherein the low frequency wave emitter (2) is screwed to the cone bottom surface (41).
9. A health care device as claimed in claim 3, characterized in that the low-frequency wave emitter (2) is a low-frequency wave emitter or a low-frequency magnetic wave emitter.
10. A health care device as claimed in claim 9, characterized in that the cone (4) is an integrally formed wooden cone.
11. A health care device, characterized in that it is arranged in front of a navel (11) of a user (1) and forms a predetermined position (P) of a predetermined distance (D) with the navel (11), the health care device at least comprising a low frequency wave emitter (2).
CN202222718849.5U 2022-10-14 2022-10-14 Health care device Active CN219049394U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202222718849.5U CN219049394U (en) 2022-10-14 2022-10-14 Health care device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202222718849.5U CN219049394U (en) 2022-10-14 2022-10-14 Health care device

Publications (1)

Publication Number Publication Date
CN219049394U true CN219049394U (en) 2023-05-23

Family

ID=86344619

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202222718849.5U Active CN219049394U (en) 2022-10-14 2022-10-14 Health care device

Country Status (1)

Country Link
CN (1) CN219049394U (en)

Similar Documents

Publication Publication Date Title
US11890471B2 (en) Vagus nerve stimulation pre-screening test
US20100099942A1 (en) Method and apparatus for electromagnetic human and animal immune stimulation and/or repair systems activation
CN114712076A (en) Cosmetic device for enhancing the recovery of mucosal tissue
CN101443074A (en) Integrated coil device and method for using the same
CN217661124U (en) Health care device
CN1980610A (en) Electromagnetic treatment apparatus and method
CN204995996U (en) Height dual -frenquency supersound electric conductance therapeutic instrument
CN103830850A (en) Multichannel ultrasonic acupuncture point stimulation method and device
CN220193829U (en) Health care device
WO2009090440A1 (en) System for the treatment of diabetes
TWM628886U (en) Health-care device
TWM638574U (en) Healthcare apparatus
CN219049394U (en) Health care device
CN117919072A (en) Health care device and health care method
US20240115457A1 (en) Health care device and health care method
TWI296103B (en)
EP0547023B1 (en) Portable electro-therapy system
TW202415360A (en) Health care methods
JP2011062373A (en) Ultrasonic oscillation unit and ultrasonic oscillation system
TWI832746B (en) health device
US20230317247A1 (en) Health care device and health care method
CN116920281A (en) Health care device and health care method
US20160339261A1 (en) Medical Bioelectric Plasma Beam
RU126598U1 (en) COMPLEX FOR CARRYING OUT PHYSIOTHERAPEUTIC PROCEDURES
TWI824937B (en) health device

Legal Events

Date Code Title Description
GR01 Patent grant
GR01 Patent grant